Connection

Haibo Qiu to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Haibo Qiu has written about Antineoplastic Agents.
Haibo Qiu
Connection Strength
0.795
Antineoplastic Agents
  1. Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy. Medicine (Baltimore). 2018 Jan; 97(2):e9097.
    View in: PubMed
    Score: 0.226
  2. [Updates on adjuvant therapy in gastrointestinal stromal tumor]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25; 20(9):961-965.
    View in: PubMed
    Score: 0.222
  3. [Association between genetic polymorphisms and variation of imatinib pharmacokinetics in gastrointestinal stromal tumors]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25; 20(9):1031-1034.
    View in: PubMed
    Score: 0.222
  4. Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients? Cancer Med. 2018 02; 7(2):317-324.
    View in: PubMed
    Score: 0.057
  5. Simultaneous quantification of imatinib and its main metabolite N-demethyl-imatinib in human plasma by liquid chromatography-tandem mass spectrometry and its application to therapeutic drug monitoring in patients with gastrointestinal stromal tumor. Biomed Chromatogr. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.055
  6. Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study. Oncotarget. 2016 May 10; 7(19):27938-45.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.